Oxygenation status of cervical carcinomas before and during spinal anesthesia for application of brachytherapy

Strahlentherapie und Onkologie

Volumn 179, Issue 9, 2003, Pages 633-640

  Weitmann, Hajo Dirk ^a   Gustorff, Burkhard ^b   Vaupel, Peter ^b   Knockel, Tomas Hendrik ^b   Pötter, Richard ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Cervical carcinoma; PO2 histography; Spinal anesthesia; Tumor oxygenation

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT; OXYGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; GYNECOLOGIC CANCER; HUMAN; OXYGEN TENSION; PATIENT MONITORING; SPINAL ANESTHESIA; SUBCUTANEOUS TISSUE; TISSUE OXYGENATION; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, SPINAL; BODY TEMPERATURE; BRACHYTHERAPY; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS;

EID: 0042825216     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1060-x     Document Type: Article

References (45)

1. Aquino-Parsons C, Green A, Minchinton AI. Oxygen tension in primary gynaecological tumours: the influence of carbon dioxide concentration. Radiother Oncol 2000;57:45-51.
2. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60: 4693-6.
3. Brizel DM, Rosner GL, Harrelson J, Prosnitz LR, Dewhirst MW. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1994;30:635-42.
4. Cooper RA, Carrington BM, Loncaster JA, Todd SM, Davidson SE, Logue JP, Luthra AD, Jones AP, Stratford I, Hunter RD, West CML. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 2000; 57:53-9.
5. Cooper RA, West CML, Logue JP, Davidson SE, Miller A, Roberts S, Statford IJ, Honess DJ, Hunter RD. Changes in oxygenation during radiotherapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1999;45:119-26.
6. Dunst J, Stadler P, Becker A, Kuhnt T, Lautenschlager C, Molls M, Haensgen G. Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers. Strahlenther Onkol 2001;177:469-73.
7. Dvorak HF, Brown LF, Detmar M, Dworak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
8. 2 histography. Br J Cancer 1992;66:919-24.
9. Fleckenstein W, Jungblut JR, Suckfu̇ll M, Hoppe W, Weiss C. Sauerstoffdruckverteilungen in Zentrum und Peripherie maligner Kopf-Hals-Tumoren. Dtsch Z Mund Kiefer Gesichts Chir 1993;12:205-11.
10. Fyles AW, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002;20:680-7.
11. Fyles AW, Milosevic M, Pintilie M, Hill RP. Cervix cancer oxygenation measured following external radiation therapy. Int J Radiat Oncol Biol Phys 1998;42:751-3.
12. Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, Chapman W, Levin W, Manchul L, Keane TJ, Hill RP. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiat Oncol 1998; 48:149-56.
13. 2, S-Phase-Anteil und p53-Status bei Zervixkarzinomen. Strahlenther Onkol 1997;173:385-7.
14. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
15. Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
16. Höckel M, Schlenger K, Höckel S, Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 1999;59:4525-8.
17. 2 tension measurements. Cancer Res 1991;51:6098-102.
18. Höckel M, Vaupel P. Prognostic significance of tissue hypoxia in cervical cancer. CME J Gynecol Oncol 2001;6:216-25.
19. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-76.
20. Höckel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol 2001;28:Suppl 8:36-41.
21. Höckel M, Vorndran B, Schlenger K, Baussmann E, Knapstein PG. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 1993;51:141-9.
22. 2-histography. Int J Radiat Oncol Biol Phys 1990;19:953-61.
23. 2-measurements as predictive assay in the treatment of primary cervical carcinoma. Radiother Oncol 1999;53:99-104.
24. Lartigau E, Le Ridant AM, Lambin P, Weeger P, Martin L, Sigal R, Lusinchi A, Luboinski B, Eschwege F, Guichard. Oxygenation of head and neck tumors. Cancer 1993;71:2319-25.
25. Lartigau E, Randrianarivelo H, Avril MF, Margulis A, Spatz A, Eschwege F, Guichard M. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 1997;7:400-6.
26. Lyng H, Sundfor K, Trope C, Rofstad EK. Oxygen tension and vascular density in human cervix carcinoma. Br J Cancer 1996;74:1559-63.
27. Lyng H, Sundfor K, Trope C, Rofstad EK. Disease control of uterine cervical cancer: Relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 2000;6:1104-12.
28. Movsas B, Chapman JD, Horwitz EM, Pinovier WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. Hypoxic regions exist in human prostate cancer. Urology 1999;53:11-8.
29. 2. A way of selecting patients for hyperoxic treatment. Strahlenther Onkol 1996;172: Suppl 2:8-9.
30. Nordsmark M, Bentzen SM, Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter-and intratumour heterogeneity. Acta Oncol 1994;33:383-9.
31. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
32. Obermair A, Bancher-Todesca D, Bilgi S, Kaider A, Kohlberger P, Müllauer-Ertl S, Leodolter S, Gitsch G. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89:1212-7.
33. Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in cervical cancer: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 2000;4:159-72.
34. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 1994;29:427-31.
35. Ravi R, Mookedee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 2000; 14:34-44.
36. 2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 2001;177:462-8.
37. Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumors: correlation between methods of measurement and response to therapy. Radiat Res 1993;136:422-34.
38. Stone HB, Minchinton AI, Lemmon M, Menke D, Brown JM. Pharmacological modification of tumor blood flow: lack of correlation between alterations of mean arterial blood pressure and changes in tumor perfusion. Int J Radiat Oncol Biol Phys 1992;22:79-86.
39. Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst, J, Koelbl H, Haensgen G. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 2002;178:378-85.
40. 2 in cervix carcinoma. Gynecol Oncol 1997;64:230-6.
41. Vaupel P. Pancreatic tumors show high levels of hypoxia [Letter to the Editor]. Int J Radiat Oncol Biol Phys 2001;50:1099-100.
42. Vaupel P, Höckel M. Hypoxie beim Zervixkarzinom: Pathogenese, Charakterisierung und biologische/klinische Konsequenzen. Zentralbl Gynäkol 2001;123:192-7.
43. Vaupel P, Kelleher DK, Höckel M. Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001;28:Suppl 8:29-35.
44. 2 tension measurements. Cancer Res 1991;51:3316-22.
45. Wong R, Fyles A, Milosevic M, Pintilie M, Hill R. Heterogeneity of polarographic oxygen electrode measurements in cervix cancer: an evaluation of intra- and inter-tumour variability, probe position and track depth. Int J Radiat Oncol Biol Phys 1997;39:405-12.